Oral Unsaturated Fat Load Impairs Postprandial Systemic Inflammation in Primary Hypercholesterolemia Patients.

Fecha de publicación: Fecha Ahead of Print:

Autores de INCLIVA

Participantes ajenos a INCLIVA

  • Collado, A
  • Perello, E

Grupos y Plataformas de I+D+i

Abstract

Context: Primary hypercholesterolemia (PH) is a lipid disorder characterized by elevated levels of cholesterol and low-density lipoprotein (LDL). Low-grade systemic inflammation is associated with PH, which might explain the higher incidence of cardiovascular diseases in this setting. Objective: To evaluate the effect of an oral unsaturated fat load (OUFL) on different immune parameters and functional consequences in patients with PH in postprandial state. Design: A commercial liquid preparation of long-chain triglycerides (Supracal(®); ?6/?3 ratio >20/1, OUFL) was administered to 20 patients and 10 age-matched controls. Whole blood was collected before (fasting state) and 4 h after administration (postprandial state). Flow cytometry was employed to determine platelet and leukocyte activation, and the levels of circulating platelet-leukocyte aggregates. Soluble markers were determined by ELISA, and the parallel-plate flow chamber was employed to study leukocyte adhesion to the dysfunctional arterial endothelium. Results: The PH group had a lower percentage of activated platelets and circulating type 1 monocytes, and blunted neutrophil activation after the OUFL, accompanied by a significant increase in the percentage of regulatory T lymphocytes. In this group, the OUFL led to a significant impairment of leukocyte adhesion to the dysfunctional [tumor necrosis factor a (TNFa)-stimulated] endothelium and reduced the plasma levels of soluble P-selectin, platelet factor-4 (PF-4)/CXCL4, CXCL8, CCL2, CCL5, and TNFa. Conclusion: The OUFL has a beneficial impact on the pro-thrombotic and pro-inflammatory state of PH patients and might be a promising macronutrient approach to dampen the systemic inflammation associated with PH and the development of further cardiovascular events.

Copyright © 2021 Collado, Domingo, Marques, Perello, Martínez-Hervás, Piqueras, Ascaso, Real and Sanz.

Datos de la publicación

ISSN/ISSNe:
1663-9812, 1663-9812

Frontiers in Pharmacology  FRONTIERS MEDIA SA

Tipo:
Article
Páginas:
656244-656244
PubMed:
33959024

Citas Recibidas en Web of Science: 4

Documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • endothelial dysfunction; inflammatory mediators; leukocytes; oral unsaturated fat load; platelet activation; primary hypercholesterolemia; systemic inflammation

Campos de Estudio

Financiación

Cita

Compartir